![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
IN Pessah, EL Durie, MJ Schiedt and I Zimanyi
Department of Pharmacology and Toxicology, School of Veterinary Medicine, University of California, Davis 95616.
Rat cardiac membrane vesicles enriched in biochemical markers of the junctional region of sarcoplasmic reticulum (SR) and exhibiting ruthenium red-sensitive rapid Ca2+ release have been prepared. Doxorubicin and seven congeners are shown to enhance the binding of [3H]ryanodine to the ryanodine receptor with a strong structural requirement. Doxorubicin enhances the binding of [3H]ryanodine to SR membranes and soluble receptor preparations and induces Ca2+ release from SR vesicles in a highly Ca2(+)-dependent manner, suggesting that anthraquinones promote the open state of the junctional Ca2+ release channel by increasing the affinity of the Ca2+ activator site for Ca2+. Doxorubicin reduces the Kd of [3H]ryanodine binding solely by enhancing the rat of association. Caffeine competes for the same site with anthraquinones, because the caffeine-activated binding of [3H]ryanodine is inhibited by doxorubicin and vice versa. The acute effect of doxorubicin on the cardiac Ca2+ release channel is fully reversible; however, long term treatment (up to 24 hr) with doxorubicin increases the sensitivity of the preparation to subsequent acute challenge with doxorubicin. The thiol-reductive agent dithiothreitol enhances, whereas the reactive disulfide 4,4'-dithiodipyridine reduces, the doxorubicin- enhanced binding of [3H]ryanodine. These results demonstrate that the acute and chronic cardiotoxicity of anthraquinones may be accounted for by a receptor-mediated mechanism. Our findings suggest that the chronic effects observed with the clinical use of anthraquinones may be the result of a receptor-mediated shift in the redox equilibrium of allosteric thiols at the ryanodine receptor complex, which in turn leads to long term sensitization of the Ca2+ release channel.
This article has been cited by other articles:
|
|
 |
|
  T. A. Ta, W. Feng, T. F. Molinski, and I. N. Pessah Hydroxylated Xestospongins Block Inositol-1,4,5-trisphosphate-Induced Ca2+ Release and Sensitize Ca2+-Induced Ca2+ Release Mediated by Ryanodine Receptors Mol. Pharmacol., February 1, 2006; 69(2): 532 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Charlier Jr., R. D. Olson, C. M. Thornock, W. K. Mercer, D. R. Olson, T. S. Broyles, D. J. Muhlestein, C. L. Larson, B. J. Cusack, and S. E. Shadle Investigations of Calsequestrin as a Target for Anthracyclines: Comparison of Functional Effects of Daunorubicin, Daunorubicinol, and Trifluoperazine Mol. Pharmacol., May 1, 2005; 67(5): 1505 - 1512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Y. Park, E. J. Kim, H. Park, K. Fields, A. K. Dunker, and C. Kang Interaction between Cardiac Calsequestrin and Drugs with Known Cardiotoxicity Mol. Pharmacol., January 1, 2005; 67(1): 97 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cherednichenko, A. V. Zima, W. Feng, S. Schaefer, L. A. Blatter, and I. N. Pessah NADH Oxidase Activity of Rat Cardiac Sarcoplasmic Reticulum Regulates Calcium-Induced Calcium Release Circ. Res., March 5, 2004; 94(4): 478 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Okamoto, J. Ogata, and K. Minami Sino-Atrial Block During Anesthesia in a Patient with Breast Cancer Being Treated with the Anticancer Drug Epirubicin Anesth. Analg., July 1, 2003; 97(1): 19 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Feng, G. Liu, R. Xia, J. J. Abramson, and I. N. Pessah Site-Selective Modification of Hyperreactive Cysteines of Ryanodine Receptor Complex by Quinones Mol. Pharmacol., May 1, 1999; 55(5): 821 - 831. [Abstract] [Full Text]
|
|
|
|
|
|
R. Zucchi, G. Yu, P. Galbani, M. Mariani, G. Ronca, and S. Ronca-Testoni Sulfhydryl Redox State Affects Susceptibility to Ischemia and Sarcoplasmic Reticulum Ca2+ Release in Rat Heart : Implications for Ischemic Preconditioning Circ. Res., November 2, 1998; 83(9): 908 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bowling, W. E. Bloomquist, M. L. Cohen, H. U. Bryant, H. W. Cole, D. E. Magee, E. R. Rowley, and C. J. Vlahos Effects of Prolonged Ethinyl Estradiol Treatment on Calcium Channel Binding and In Vivo Calcium-Mediated Hemodynamic Responses in Ovariectomized Rats J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 218 - 225. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Zucchi and S. Ronca-Testoni The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. El-Hayek, A. J. Lokuta, C. Arévalo, and H. H. Valdivia Peptide Probe of Ryanodine Receptor Function J. Biol. Chem., December 1, 1995; 270(48): 28696 - 28704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-X. Wang and M. Korth Effects of Doxorubicin on Excitation-Contraction Coupling in Guinea Pig Ventricular Myocardium Circ. Res., April 1, 1995; 76(4): 645 - 653. [Abstract] [Full Text]
|
|
|
|
|
|
S. Treves, G. Feriotto, L. Moccagatta, R. Gambari, and F. Zorzato Molecular Cloning, Expression, Functional Characterization, Chromosomal Localization, and Gene Structure of Junctate, a Novel Integral Calcium Binding Protein of Sarco(endo)plasmic Reticulum Membrane J. Biol. Chem., December 8, 2000; 275(50): 39555 - 39568. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
